Skip to Main Content

Paper Details

OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells.
Front Oncol
3
2022
Author NameAffiliation
Thomas HelledayKarolinska Institutet
Thomas HelledaySheffield Cancer Centre, University of Sheffield
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Javier Ben??tez
Ana OsorioSpanish National Cancer Research Centre (CNIO)
Ana OsorioFamilial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO)
Ana Osorio
  • 1 - 7

Datasets

Release 1.2